Clinical Trials Logo

Hypoplastic Left Heart Syndrome clinical trials

View clinical trials related to Hypoplastic Left Heart Syndrome.

Filter by:

NCT ID: NCT00573066 Completed - Tetralogy of Fallot Clinical Trials

Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery

InfantDex
Start date: May 2004
Phase: Phase 1
Study type: Interventional

This study is being conducted to determine what dexmedetomidine does to the body and in turn, what how the body handles the medication. This medication, for the purpose of this trial, is used as a short-term sedative for infants who are immediately post-operative from cardiac surgery and have a breathing tube and are breathing with the assistance of a mechanical ventilator or breathing machine.

NCT ID: NCT00571233 Completed - Clinical trials for Hypoplastic Left Heart Syndrome

Biomarker Study for Heart Failure in Children With Single Ventricle Physiology

BHFSVP
Start date: February 2007
Phase: N/A
Study type: Observational

The purpose of this study is to determine if children with heart disease where there is only one pumping chamber("ventricle") have proteins (biomarkers") in the blood that can be used to monitor the function of their heart.

NCT ID: NCT00513240 Completed - Clinical trials for Congenital Heart Disease

Erythropoetin Neuroprotection for Neonatal Cardiac Surgery

Start date: September 2006
Phase: Phase 1/Phase 2
Study type: Interventional

Brain problems occur in neonatal open heart surgery with a frequency of 20-70%, seen on neurological examination, brain imaging such as magnetic resonance imaging (MRI), or long term development problems such as learning disorders and hyperactivity syndromes. This study aims to determine if erythropoetin, a natural hormone made in the body, protects the brain from damage when given in high doses before and during neonatal open heart surgery. We will use brain MRI, brain wave tests (EEG), neurological examination, and long term developmental outcome testing to see if erythropoetin is better than salt water injection (placebo) in protecting the brain.

NCT ID: NCT00507819 Completed - Clinical trials for Hypoplastic Left Heart Syndrome

Sildenafil After the Fontan Operation

SAFO
Start date: December 2007
Phase: Phase 2
Study type: Interventional

In this study, the investigators will evaluate the effect of sildenafil on exercise tolerance in patients with a single cardiac ventricle who have undergone the Fontan operation. The investigators will also evaluate echocardiographic measures of ventricular function and measure quality of life changes using two validated quality of life measures. The hypothesis is that sildenafil will result in increased exercise tolerance in patients who have had the Fontan operation as compared to placebo.

NCT ID: NCT00464100 Completed - Clinical trials for Hypoplastic Left Heart Syndrome

Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes

NIRS-ND
Start date: March 1, 2006
Phase:
Study type: Observational

We believe that how a baby with Hypoplastic Left Heart Syndrome (HLHS)does after a major open heart operation, measured by things like blood pressure, oxygen saturation, heart rate and others, may have an impact on development. Studying how post-operative condition impacts outcomes may help us to protect babies better when they undergo surgery. This study will look at some of the long-term outcomes of children with HLHS, including both mental development and quality of life. We will use information from your child's medical record to see if early oxygen delivery has an impact on later development.

NCT ID: NCT00399555 Completed - Clinical trials for Congenital Heart Disease

Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome

Start date: November 2006
Phase: N/A
Study type: Observational

There have been many improvements in the care of children with hypoplastic left heart syndrome (HLHS). This has helped these children survive longer. Because these children now live longer, researchers are recognizing developmental disabilities (the children are behind in their thinking or physical activity) in children with hypoplastic left heart syndrome. The purpose of this research study is to help the investigators learn more about developmental disabilities in children with hypoplastic left heart syndrome. During the time of your child's first surgery for hypoplastic left heart syndrome, a monitor was placed on your child's forehead to measure the oxygen levels in the brain. This monitor is called Near Infrared Spectrometry (NIRS). The researchers involved in this study want to know if oxygen levels in the blood vessels of the brain have any effect on developmental disabilities later in life in children with hypoplastic left heart syndrome. The researchers plan to enroll 60 research subjects.

NCT ID: NCT00308217 Completed - Clinical trials for Hypoplastic Left Heart Syndrome

Single Ventricle Outcome

Start date: June 2005
Phase: N/A
Study type: Observational

The objective of this research proposal is to perform an ongoing single institution prospective clinical trial examining the overall clinical outcome of children with single ventricle physiology.

NCT ID: NCT00166101 Completed - Surgery Clinical Trials

NIRS in Neonatal Cardiac Surgery

Start date: August 2002
Phase: N/A
Study type: Observational

Due to the small size of infants and the use of bypass machines, physicians have difficulty assessing whether the infant's brain and body is getting enough oxygen during heart surgery. This study compares continuous monitoring via the NIRS (Near Infrared Spectroscopy) to the traditional methods of determining oxygen saturation.

NCT ID: NCT00156455 Withdrawn - Clinical trials for Obstructive Sleep Apnea Syndrome

Sleep Disordered Breathing in Children With Single Ventricle Physiology

Start date: September 2004
Phase: N/A
Study type: Observational

This is an exploratory study designed to evaluate the incidence of, and to quantify sleep disordered breathing following stage I Norwood reconstructive surgery. Sleep disordered breathing will be correlated with: 1. Elevations in pulmonary vasculature resistance at the time of Stage II surgery. 2. Risks of death